secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRIDEX CORP (IRIX)
CIK:        0001006045
Form:       8-K
Filed at:   2022-11-10T23:59:59+00:00
Accession:  0000950170-22-024501
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IRIDEX reports record Q3 revenue $14.6M, net loss narrows to $1.8M; maintains FY guidance
--------------------------------------------------------------------------------

- Total revenue $14.6M, +10% YoY, record Q3; net loss $1.8M ($0.11/share) vs $2.2M loss ($0.14) prior year.
- Retina product revenue $8.8M (+13% YoY); Cyclo G6 revenue $3.5M (+10%).
- FDA clearance of next-gen Pascal scanning laser system; first shipments in Q4.
- FY revenue guidance maintained at $56-58M; probe units expected ~60,000 (down from 61-63k).
- Cash $15.9M, used $2.1M in quarter including $0.5M inventory pre-orders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006045/000095017022024501/0000950170-22-024501-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006045/000095017022024501/irix-20221110.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-024501

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer